Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$835,627
-$13,252,945 QoQ
Shares Held
15,941
-93.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#382
of 1,033 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. GSK ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
90,150 | $17,094,243 | |
| 2 | SNY |
Sanofi
|
115,761 | $4,938,364 | |
| 3 | NVO |
Novo Nordisk A S
|
47,719 | $2,287,648 | |
| 4 | GSK |
GSK plc
This page
|
15,941 | $835,627 | |
| 5 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,941 | $245,225 | |
| 7 | PFE |
Pfizer Inc
|
7,242 | $174,387 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,302 | $132,641 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $835,627 | 15,941 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $14,088,572 | 255,274 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,469,028 | 356,220 | Shares | Defined | 2026-02-17 | |
| 2024-06-30 | $19,410,776 | 504,176 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $38,805,155 | 1,047,090 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,515,951 | 262,509 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $29,855,628 | 837,700 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $28,264,680 | 794,398 | Shares | Defined | 2023-05-11 | |
| 2021-12-31 | $9,747,645 | 225,362 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||